I. Gibbens

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

Tim Eisen, T. Ahmad, Keith T. Flaherty et al. · British Journal of Cancer · 2006 · 636 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I trial of BAY 43–9006 (sorafenib) combined with dacarbazine (DTIC) in metastatic melanoma patients

Tim Eisen, T. Ahmad, M. Gore et al. · Journal of Clinical Oncology · 2005 · 50 citations

Medicine, Oncology, Pharmacology +17

A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma

James Larkin, Sarah Hughes, Debbie Beirne et al. · British Journal of Cancer · 2006 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

Tim Eisen, Richard Marais, Annette Affolter et al. · British Journal of Cancer · 2011 · 43 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Attitudes to chemotherapy in patients with ovarian cancer

Richard T. Penson, Fiona L. Dignan, Michael V. Seiden et al. · Gynecologic Oncology · 2004 · 34 citations

Medicine, Gynecology, Oncology +12